- Home
- LNTH vs MKTX Comparison
LNTH vs MKTX Comparison
Compare LNTH & MKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LNTH | MKTX |
|---|---|---|
| Founded | 1956 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 6.0B |
| IPO Year | 2015 | 2004 |
Fundamental Metrics
Financial Performance| Metric | LNTH | MKTX |
|---|---|---|
| Price | $67.20 | $183.07 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 10 |
| Target Price | $78.00 | ★ $211.30 |
| AVG Volume (30 Days) | ★ 1.1M | 739.5K |
| Earning Date | 11-06-2025 | 02-05-2026 |
| Dividend Yield | N/A | ★ 1.65% |
| EPS Growth | N/A | ★ N/A |
| EPS | 2.39 | ★ 5.87 |
| Revenue | ★ $1,525,933,000.00 | $839,263,000.00 |
| Revenue This Year | $0.01 | $6.33 |
| Revenue Next Year | $0.52 | $8.10 |
| P/E Ratio | ★ $28.14 | $31.31 |
| Revenue Growth | 1.95 | ★ 3.37 |
| 52 Week Low | $47.25 | $156.17 |
| 52 Week High | $111.29 | $232.84 |
Technical Indicators
Market Signals| Indicator | LNTH | MKTX |
|---|---|---|
| Relative Strength Index (RSI) | 66.41 | 65.27 |
| Support Level | $66.20 | $181.22 |
| Resistance Level | $68.84 | $183.54 |
| Average True Range (ATR) | 1.75 | 2.81 |
| MACD | -0.00 | 0.56 |
| Stochastic Oscillator | 81.29 | 88.47 |
Price Performance
Historical ComparisonAbout LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About MKTX MarketAxess Holdings Inc.
Founded in 2000, MarketAxess is a leading electronic fixed-income trading platform that connects broker/dealers and institutional investors. The company is primarily focused on credit based fixed income securities with its main trading products being US investment-grade and high-yield bonds, Eurobonds, and Emerging Market corporate debt. Recently the company has expanded more aggressively into Treasuries and municipal bonds with the acquisitions of LiquidityEdge and MuniBrokers in 2019 and 2021, respectively. The company also provides pre- and post-trade services with its acquisition of Regulatory Reporting Hub from Deutsche Börse Group in 2020 adding to its product offerings.